Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 9/20 | 0.52 |
| ▸ | SOD1 | P00441 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.44 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7970502 | 0.91 | QPCT (0.63) | QPCTSOD1 | |
| Hydrochloric Acid SCHEMBL3872082 | 0.90 | QPCT (0.62) | QPCTSOD1 | |
| SCHEMBL18457438 | 0.79 | QPCT (0.56) | QPCTSOD1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL4280470 | 0.77 | KAT2B (0.51) | QPCTSOD1CYP19A1POLBMAPT | |
| SCHEMBL7374461 | 0.76 | QPCT (0.45) | QPCTCYP19A1CYP11B1CYP11B2TBXAS1 | |
| Hydrochloric Acid SCHEMBL6271312 | 0.74 | MAPT (0.38) | QPCTCYP1A2CYP2D6MAPT | |
| SCHEMBL15291900 | 0.74 | SOD1 (0.49) | QPCTSOD1CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL9940703 | 0.74 | QPCT (0.57) | QPCTSOD1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6201094 | 0.73 | MAPT (0.52) | CYP1A2CYP3A4CYP2D6MAPT | |
| SCHEMBL11011309 | 0.73 | MEN1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080096861-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096861-A1 | Chemical Compounds | CCR5, CXCR4, CXCR3 | QPCT 1537/4885SOD1 4701/4885CYP19A1 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.